This information was published on 2025-05-08T08:19:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2542413 (IR 1827871) |
| (220) |
09 Apr 2025
|
| (300) |
FR, 10 Oct 2024, 5089201
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical products for the prevention and treatment of cardiovascular diseases. |
| (540) | PIBAXAM |
| (550) | Word |
| (730) |
BIOFARMA
|
Find out more about publications on the About page.